Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 4, 2024 -- Some pesticides are associated with increased prostate cancer incidence and mortality, according to a study published online Nov. 4 in Cancer.
Simon John Christoph Soerensen, M.D., from the Stanford University School of Medicine in California, and colleagues examined the potential role of agricultural pesticide exposure in prostate cancer incidence and mortality. The annual use of 295 distinct pesticides was measured and the associations with prostate cancer incidence and mortality rates in the contiguous United States were assessed. Data were analyzed for 1997-2001 pesticide use with 2011-2015 outcomes and 2002-2006 pesticide use with 2016-2020 outcomes (discovery and replication cohorts, respectively).
The researchers found that across both cohorts, 22 pesticides showed consistent, direct associations with prostate cancer incidence. Four of these pesticides were also associated with prostate cancer mortality. Each one-standard deviation increase in log-transformed pesticide use corresponded to incidence increases per 100,000 individuals in the replication cohort (6.56, 6.18, 3.20, and 2.82 for trifluralin, cloransulamâmethyl, diflufenzopyr, and thiamethoxam, respectively).
"Public health efforts to reduce the burden of prostate cancer should consider pesticides as environmental exposures that may contribute to the incidence of, and mortality related to, prostate cancer," the authors write
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2024
Read this next
Chemicals From Personal Care Products Detected in Pregnant, Lactating Women
TUESDAY, Nov. 19, 2024 -- The use of personal care products (PCPs) such as hair dyes may be a modifiable source of per- and polyfluoroalkyl substance (PFAS) exposure in pregnant...
Overtreatment of Prostate Cancer Increasing in Men With Short Life Expectancy
WEDNESDAY, Nov. 13, 2024 -- In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk prostate cancer, but increased...
Mixed Link Seen for Gestational Exposure to Flame-Retardant Chemicals and Childhood Obesity
TUESDAY, Nov. 12, 2024 -- The association between gestational organophosphate ester (OPE) exposure and obesity in childhood is mixed, according to a study published in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.